Bullish
Fate Therapeutics Showcases FT819 Clinical Activity in SLE
Fate Therapeutics showcased positive clinical data for its off-the-shelf CAR T-cell programs FT819, FT839, and FT836 at the 2026 ASGCT Annual Meeting....
FATE
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (1)
Neutral (0)
Bearish (0)
Latest FATE News
Bullish
Research FATE on:
Ad Space